Skip to main content
SpringerLink
Log in

Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. F. F. Farris, F. G. King, R. L. Dedrick, and C. L. Litterst. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum(II) (DDP) in the tumored rat.J. Pharmacokin. Biopharm. 13:13–40 (1985).

    Article  CAS  Google Scholar 

  2. F. G. King, R. L. Dedrick, and F. F. Farris. Physiological pharmacokinetic modeling of cis-dichlorodiammmeplatinum(II) (DDP) in several species.J. Pharmacokin. Biopharm. 14:131–155 (1986).

    Article  CAS  Google Scholar 

  3. F. F. Farris, R. L. Dedrick, and F. G. King. Cisplatin pharmacokinetics: applications of a physiological model.Toxicol. Letters 43:117–137 (1988).

    Article  CAS  Google Scholar 

  4. Z. H. Siddik, M. Jones, F. E. Boxall, and K. E. Harrap. Comparative distribution and excretion of carboplatin and cisplatin in mice.Cancer Chemother. Pharmacol. 21:19–24 (1988).

    Article  CAS  PubMed  Google Scholar 

  5. Z. H. Siddik, D. Newell, F. E. Boxall, and K. E. Harrap. The comparative pharmacokinetics of carboplaten and cisplatin in mice and rats.Biochem. Pharmacol. 36:1925–1932 (1987).

    Article  CAS  PubMed  Google Scholar 

  6. C. Jacobs. The handling of platinum by the human kidney. In D. C. H. McBrien and T. F. Slater (eds.),Biochemical Mechanisms of Platinum Antitumor Drugs, IRL Press, Oxford, U.K. (1986).

    Google Scholar 

  7. F. G. King and R. L. Dedrick. Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in the mouse, dog and monkey.Cancer Treat. Rep. 63:1939–1947 (1979).

    CAS  PubMed  Google Scholar 

  8. F. G. King, R. L. Dedrick, J. M. Collins, H. B. Matthews, and L. S. Birnbaum. Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species.Toxicol. Appl. Pharmacol. 67:390–400 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. F. G. King and R. L. Dedrick. Physiologic model for the pharmacokinetics of 2′-deoxyco-formycin in normal and leukemic mice.J. Pharmacokin. Biopharm. 9:519–534 (1981).

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Franklin G. King

    Present address: Department of Chemical Engineering, North Carolina A&T State University, 27411, Greensboro, North Carolina

Authors and Affiliations

  1. Biomedical Engineering and Instrumentation Program, National Center for Research Resources, National Institutes of Health, Building 13, Room 3W13, 20892, Bethesda, Maryland

    Franklin G. King & Robert L. Dedrick

Authors
  1. Franklin G. King
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert L. Dedrick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

King, F.G., Dedrick, R.L. Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse. Journal of Pharmacokinetics and Biopharmaceutics 20, 95–99 (1992). https://doi.org/10.1007/BF01143187

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01143187

Key words

Search

Navigation